WATERTOWN, Mass.--(BUSINESS WIRE)--April 19, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC - News), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will report its first quarter 2006 financial results after the U.S. Financial Markets close on Wednesday, April 26, 2006. Following the announcement, Panacos will hold a conference call to discuss the results and provide an update on the Company's development programs. Dr. Samuel K. Ackerman, President and CEO, will lead the call.
